ArticleEuropean journal of neurology2022

Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients.

Iddo Magen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.